IP Library › Granted Patent US 11,085,057
Granted Patent B2
US 11,085,057 · App. 15/773,543 · Granted Aug 10, 2021

Compositions and methods for modifying a target nucleic acid

Inventors: Jacob E. Corn (Berkeley, CA); Christopher D. Richardson (Berkeley, CA)
Assignee: The Regents of the University of California
C12N15/907A61K31/7088C12N9/22C12N15/102C12N15/11C12N15/113C12N2310/20
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,085,057
App. No.
15/773,543
Granted
Aug 10, 2021
Kind
B2
Abstract

The present disclosure provides a system for editing genomic DNA, the system comprising an asymmetric donor DNA template; and methods of editing genomic DNA involving use of an asymmetric donor DNA template. The present disclosure provides a system for editing genomic DNA, the system comprising a Cas9 polypeptide with reduced enzymatic activity; and methods of editing genomic DNA involving use of a Cas9 polypeptide with reduced enzymatic activity.

Claims (11)

1. A method of editing genomic DNA of a eukaryotic cell, wherein the genomic DNA comprises a target strand and a non-target strand, the method comprising introducing into the cell:

(a) a Cas9 guide RNA, or one or more nucleic acids encoding said Cas9 guide RNA, wherein the Cas9 guide RNA hybridizes to a target sequence of the target strand of the genomic DNA;

(b) an asymmetric double stranded or single stranded donor DNA molecule comprising a 5′ homology arm and a 3′ homology arm, wherein the 3′ homology arm is 20 to 50 nucleotides in length, is shorter than the 5′ homology arm, and comprises at least 10 consecutive nucleotides of said target sequence, and wherein the ratio of the length of the 5′ homology arm to the 3′ homology arm is from 2.5:1 to 5:1; and

(c) a Cas9 protein or a nucleic acid encoding said Cas9 protein,

wherein (i) the Cas9 protein forms a complex with the Cas9 guide RNA thereby guiding the Cas9 protein to said target sequence, (ii) the 3′ homology arm of the donor DNA molecule hybridizes to the non-target strand of the genomic DNA, and (iii) a nucleotide sequence of the donor DNA molecule is incorporated into the genomic DNA.

2. The method according to claim 1 , wherein the Cas9 protein comprises a functional RuvC domain and cleaves at least the non-target strand of genomic DNA.

3. The method according to claim 1 , wherein the Cas9 protein comprises a functional HNH domain and cleaves at least the target strand of genomic DNA.

4. The method according to claim 1 , wherein the 5′ homology arm of the donor DNA molecule is 50 to 200 nucleotides in length.

5. The method according to claim 1 , wherein the donor DNA molecule comprises a heterologous nucleotide sequence, between the 5′ and 3′ homology arms, that is incorporated into the genomic DNA.

6. The method according to claim 1 , wherein the donor DNA molecule comprises one or more synthetic modifications selected from: a base modification, a sugar modification, and a backbone modification.

7. The method according to claim 1 , wherein the non-target strand comprises a protospacer-adjacent motif (PAM), wherein the 3′ homology arm comprises at least 10 consecutive nucleotides that are complementary to a nucleotide sequence in the PAM-distal non-target strand, and wherein the 5′ homology arm does not comprise at least 10 consecutive nucleotides that are complementary to a nucleotide sequence in the PAM-distal non-target strand.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 19, 2021
From: CORN, JACOB E.; RICHARDSON, CHRISTOPHER D.
To: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
Reel/Frame 054958/0134 →
Continuity (2)
Provisional Application 62262189 · Dec 2, 2015
Related Publication 20180320202A1 · Nov 8, 2018